Rankings / Cognitive — Nootropics
Pitolisant (Wakix)
Cognitive · H3 receptor inverse agonist
Tier B+
What this is
Harmony Biosciences; brand Wakix. FDA-approved 2019 for narcolepsy. The non-controlled status is the key differentiator — uniquely accessible without DEA scheduling concerns. Clinical effect somewhat smaller than modafinil/solriamfetol but unique mechanism makes it complementary rather than redundant.
Mechanism
Histamine H3 receptor inverse agonist/antagonist — increases endogenous histamine release in tuberomammillary nucleus → cortical wakefulness; non-controlled, non-amphetamine mechanism
Dose & route
17.8-35.6 mg PO once daily morning
Citations
- https://pubmed.ncbi.nlm.nih.gov/41233821/
- https://pubmed.ncbi.nlm.nih.gov/29475822/
- https://pubmed.ncbi.nlm.nih.gov/31230167/
Links go to the source. If a link is dead or you want something re-checked, let me know.
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.